KMTS

Kestra Medical Technologies, Ltd. (KMTS)

Market Closed

25 Jul, 20:00

NASDAQ (NGS)

16. 55

-0.42

-2.47%

- Market Cap

- P/E Ratio

- Div Yield

171,528 Volume

- Eps

$ 16.97

Previous Close

Day Range

16.02 17.16

Year Range

13.25 26.15

Want to track KMTS and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 67 days

Summary

KMTS closed today lower at $16.55, a decrease of 2.47% from yesterday's close, completing a monthly increase of or $16.55. Over the past 12 months, KMTS stock gained .

KMTS is not paying dividends to its shareholders.

The last earnings report, released on Jul 24, 2025, exceeded the consensus estimates by 0.53%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Oct 01, 2025.

The stock of the company had never split.

The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

Overview
Earnings
News

KMTS Chart

Kestra Medical: Skipping A Heartbeat

Kestra Medical Technologies, Ltd. shows strong sales growth but faces significant operating losses and a concerning slowdown in sequential revenue growth. Despite a large addressable market and innovative cardiac device, the company's one-product focus and high valuation amplify risks. Recent quarters reveal only modest revenue increases, casting doubt on the sustainability of Kestra's growth trajectory post-IPO.

Seekingalpha | 1 month ago

Kestra Medical Technologies: A Potential Promising Public Offering

Kestra Medical Technologies has seen rapid growth but incurs substantial operating losses, making its valuation exercise a hard one. The company's Cardiac Recovery System, including the ASSURE WCD, addresses a significant market need for sudden cardiac arrest intervention. Despite strong product adoption and a large addressable market, risks include high losses, being a one-product business, and potential growth slowdown.

Seekingalpha | 4 months ago

Kestra Medical Technologies aims to raise $150M in IPO

Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.

Geekwire | 4 months ago